GAAPP Annual Scientific Meeting
Prague, June 30th, 2022
After two years of exclusively online events, the 2022 Scientific Meeting was conducted in a hybrid format (live streaming and in-person) in Prague, the Czech Republic, on June 30th. Before the EAACI Conference.
You can watch the recording of the whole session below. Open the video on Youtube clicking “Watch on YouTube” or clicking this link so you can access, through the video description, each presentation directly.
Summary of the Sessions
The 6th Annual Scientific Meeting of GAAPP was held on Thursday, June 30th, in Prague, Czech Republic. Speakers from around the world were invited to provide updates to our participants, participating in person and virtually, on topics related to Food Allergy, COVID-19 and its long-term implications, the management of Chronic Urticaria, and the 2022 GOLD and GINA Guidelines.
Update in Food Allergy Management: New Ga2LEN ANACare Guidelines for Food Allergy Management
Prof. M. Antonella Muraro, Head of the Veneto Region Referral Centre for Food Allergy Diagnosis and Treatment at Padua General University Hospital in Italy, presented an Update in Food Allergy Management: New Ga2LEN ANACare Guidelines for Food Allergy Management. These guidelines were launched at the WAO & BSACI Meeting in Scotland in April 2022 and are currently under review by the World Allergy Journal. Prof. Muraro shared the need for GA2LEN Guidelines due to a changing landscape in food allergy. The GA2LEN Task Force recommends dietary interventions (elimination diets and restrictions), Oral immunotherapy (OIT) under specialist supervision, biologic therapy, and education for individuals and families that identify and manage risks.
How COVID Impacts the Future
Douglas H. Jones, MD, FAAAAI, FACAAI, cofounder of Global Food Therapy, Food Allergy Support Team, and the Director at Rocky Mountain Allergy at Tanner Clinic in the United States, presented How COVID Impacts the Future. Dr. Jones discussed the current state of COVID and the long-haul implications. Globally there have been ½ billion cases, with over 6 million deaths. Takeaways included putting mindfulness over emotion and being aware of the information you consume and where it comes from. COVID is here to stay; this is the new normal.
How to Improve the Management of Patients with Chronic Urticaria.
Prof. Marcus Maurer from the Urticaria Center of Reference and Excellence (UCARE) and the Institute of Allergology in Berlin, Germany, shared his presentation on How to Improve the Management of Patients with Chronic Urticaria.
Prof. Maurer emphasized the debilitating and often uncontrolled nature of chronic urticaria and the importance of treatment. Often time, patients have more than one form of urticaria, which can occur together to increase symptoms. The recommendation is to treat the disease until it is gone. Management related to the patient’s UCT score results were detailed.
2022 GINA Guidelines Update
Dr. Anshum Aneja Arora, a pulmonologist at Aro Health in Gurgram, India, presented the 2022 GINA Guidelines Update. The guidelines are reviewed twice a year. The Guidelines continue to support that SABA use is viewed as the less effective treatment and should not be used as a standalone treatment as it increases the risk of death and exacerbation. While the GINA 2020 Guidelines directed Oral corticosteroid (OCS) as a last resort, the 2022 Guidelines state that OCS should be the last resort. The future discussions will include answering the debated question: Do we eliminate the conversation of mild asthma?…
Updates on the GOLD Guidelines
Updates on the GOLD Guidelines Dr. Daniel William Ray MD, a pulmonologist at Northshore University Health System in Chicago, shared the 2022 GOLD Guidelines Update, which included the further definition of COPD stages – early, mild, young, and pre-, and the importance of screening individuals early. LABA language was also updated for patients with Asthma and COPD overlapping. Patients should be aware that breathlessness is not normal.
With generous support from our Sponsors: